Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer

Chandra P. Belani, Wei Wang, David H. Johnson, Henry Wagner, Joan Schiller, Michael Veeder, Minesh Mehta

Research output: Contribution to journalArticlepeer-review

136 Scopus citations

Fingerprint Dive into the research topics of 'Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences